Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02991248 · ClinicalTrials.gov registry record · NA
Improve Dynamic Lateral Balance of Humans With SCI
A NA study of Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT02991248: Recruiting NA study of Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab.
NCT02991248 is a NA study of Spinal Cord Injury that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 54 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02991248, a NA study of Spinal Cord Injury, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to test whether pelvis perturbation training paired with transcutaneous spinal direct current stimulation (tsDCS) will be effective in improving dynamic balance and locomotor function in humans with SCI. One group will receive pelvis perturbation training paired with tsDCS, one group will receive pelvis perturbation training paired with sham, and one group will receive treadmill training only.
Primary Outcome
gait speed
Conditions Studied
Interventions
- DEVICE robotic training
- DEVICE spinal cord electrical stimulation
- DEVICE treadmill
Study Locations (1)
Illinois
- Abilitylab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT02991248 shows while recruiting
NCT02991248 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which robotic training is the first listed.
NCT02991248 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02991248 about?
NCT02991248 is a clinical study titled "Improve Dynamic Lateral Balance of Humans With SCI". This study is to test whether pelvis perturbation training paired with transcutaneous spinal direct current stimulation (tsDCS) will be effective in improving dynamic balance and locomotor function in humans with SCI. One group will receive pelvis perturbation training paired with tsDCS, one group w...
What is the current status of trial NCT02991248?
This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2018-11-01. Estimated completion is 2025-12-30.
What conditions does trial NCT02991248 study?
This clinical trial studies the following conditions: Spinal Cord Injury.
What interventions are being tested in trial NCT02991248?
The interventions under investigation include: robotic training (DEVICE), spinal cord electrical stimulation (DEVICE), treadmill (DEVICE).
Who is sponsoring clinical trial NCT02991248?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02991248 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02991248's enrollment target sits among peer trials
54 35th of 99 higher than 65 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
- NCT03081910 · 54 participants · Phase 1
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI